trial · primary record
Finerenone (Kerendia, BAY94-8862)
Left Ventricular Systolic Dysfunction
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 117 |
| Primary completion | 2030-12-30 |
| Primary endpoint | Number of participants with treatment-emergent adverse events (TEAEs) |
| Registry ID | NCT07192952 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:29.801Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07192952
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.